NCT01669278 is a NA clinical trial of Endosheath in Otorhinolaryngologic Diseases, sponsored by University of Alberta.

Who is sponsoring NCT01669278?

NCT01669278 is sponsored by University of Alberta.

What drugs are being tested in NCT01669278?

Interventions in NCT01669278: Endosheath.

What condition does NCT01669278 study?

NCT01669278 studies Otorhinolaryngologic Diseases.

Is NCT01669278 still recruiting?

NCT01669278 is currently withdrawn. Last updated 16 September 2016.

Last reviewed 2016-09-16 · How we verify

NCT01669278

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Office-Based Sheathed Flexible Nasopharyngoscopy

Withdrawn NA Last updated 16 September 2016

What this trial tests

NA trial testing Endosheath in Otorhinolaryngologic Diseases. Withdrawn.

Quick facts

Lead sponsor	University of Alberta
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Sites	1 location across Canada

Drugs / interventions tested

Endosheath

Conditions studied

Otorhinolaryngologic Diseases — all drugs for Otorhinolaryngologic Diseases →

Sponsor

University of Alberta

Who can join

17 and older, any sex, with Otorhinolaryngologic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The processing of standard flexible nasopharyngoscopes is a time-consuming and costly process. The goal of this study is to determine the efficiency and cost-effectiveness of sheathed flexible endoscope in an office setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Alberta trials

Trials by the same sponsor.

NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01669278 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alberta
Last refreshed: 16 September 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01669278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing